Related Experiment Video
Updated: Dec 20, 2025
07:36
Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody
Published on: May 16, 2020
5.7K
Translin-Trax: Considerations for Oncological Therapeutic Targeting
Ramsay J McFarlane1, Jane A Wakeman1
1North West Cancer Research Institute, School of Medical Sciences, Bangor University, Deiniol Road, Bangor, Gwynedd LL57 2UW, UK.
Trends in Cancer
|May 28, 2020
Summary
Dicer-deficient cancers degrade tumor-suppressing miRNA precursors via Translin-Trax (Tn-Tx) ribonuclease, leading to poor prognoses. Inhibiting Tn-Tx may offer new cancer therapy strategies, but its complex functions require careful consideration for therapeutic design.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Dicer-deficient cancers are associated with poor patient prognoses.
- Tumor-suppressing microRNA (miRNA) precursors are degraded by the Translin-Trax (Tn-Tx) ribonuclease in these cancers.
- This degradation contributes to the adverse outcomes observed in Dicer-deficient tumors.
Purpose of the Study:
- To explore the therapeutic potential of inhibiting the Translin-Trax (Tn-Tx) ribonuclease.
- To analyze the complex biological roles of Tn-Tx and their implications for designing targeted cancer therapies.
- To understand how Tn-Tx's multifaceted functions might affect therapeutic strategies.
Main Methods:
- Review of existing literature on Dicer-deficient cancers and miRNA biogenesis.
- Analysis of the known functions and pathways involving the Translin-Trax (Tn-Tx) ribonuclease.
- Conceptual exploration of therapeutic intervention points targeting Tn-Tx.
Main Results:
- Translin-Trax (Tn-Tx) ribonuclease activity is a key factor in the poor prognosis of Dicer-deficient cancers.
- Inhibition of Tn-Tx presents a potential therapeutic avenue.
- The diverse biological functions of Tn-Tx introduce complexities that must be addressed in therapeutic development.
Conclusions:
- Targeting Translin-Trax (Tn-Tx) offers a promising, yet complex, strategy for treating Dicer-deficient cancers.
- Further research is needed to navigate the intricate biological roles of Tn-Tx for effective therapeutic design.
- Understanding Tn-Tx's multifaceted functions is crucial for developing safe and effective cancer treatments.
Related Concept Videos
02:57Targeted Cancer Therapies
8.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.5K
02:50Combination Therapies and Personalized Medicine
5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
01:27Nonlinear Pharmacokinetics: Role of Transporters
214
A drug's nonlinear kinetics can be influenced by a diverse range of transporter proteins that serve as crucial players in drug distribution. These transporters, found within cells, can enhance or reduce local drug concentrations by facilitating the influx or efflux of drugs. For instance, the expression of xenobiotic transporters can be influenced by factors such as age and gender, potentially impacting the linearity of drug response.
Polymorphisms occurring in drug transporters can alter...
Polymorphisms occurring in drug transporters can alter...
214
02:49Cancer Therapies
9.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.7K
01:24Tissue-Drug Binding: Localization of Drugs and its Significance
331
Body tissues, comprising approximately 40% of the body weight, are crucial in drug distribution and localization. These tissues can serve as drug storage sites, competing with plasma binding sites for drug molecules.
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine...
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine...
331